Research Goals and Approach


Prior to the founding of FCF, fibrolamellar carcinoma received minimal research attention. Since then, FCF has committed over $8 million to fund research studies conducted by many of the most prestigious and innovative research and academic institutions in the country. FCF-funded research has included a broad range of basic, translational and clinical studies (Click here to view an explanation of these three types of research).

Key types of research supported by FCF

As a leading funder of FLC research, our goal is to transform the fibrolamellar research landscape. By supporting cutting-edge research, actively recruiting new investigators to the disease, and working together to understand the origin and development of FLC, we hope to create more effective therapies and ultimately find a cure for the disease.

Research Approach

As a foundation, our research funding decisions are driven by three simple principals:

Our main objective is to find a cure for FLC. Because so much is still unknown about the disease, finding that cure requires:

  • Funding a range of clinical, translational and basic research
  • Taking educated risks, since not all initiatives will be successful.

We want our investments to make a difference and help bridge existing research gaps. With so much to be done, we:

  • Prefer to support promising projects less likely to get traditional funding
  • Prioritize seed funding of projects with potential long-term payoffs
  • Avoid funding redundant efforts or displacing existing funding sources.

We believe the fastest path to a cure requires researchers to work together collaboratively – rapidly sharing information, materials, and expertise. We:

  • Encourage collaboration between scientists and institutions with our grants program.
  • Invite FLC researchers to a biennial research summit where they can share ideas, resources, and solutions, and help shape FCF’s research agenda.

Current research priorities >